PMID- 8144933 OWN - NLM STAT- MEDLINE DCOM- 19940429 LR - 20071114 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 152 IP - 7 DP - 1994 Apr 1 TI - Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. PG - 3541-9 AB - Monocyte chemoattractant protein-1 (MCP-1) is a member of the chemokine-beta (or C-C) family of cytokines. Murine MCP-1, first identified as the JE gene, differs from human MCP-1 in molecular size and extent of glycosylation. We have used Chinese hamster ovary cells to express recombinant murine MCP-1 and find that its predominant form is a microheterogeneous protein of M(r) approximately 25,000. Most of MCP-1's microheterogeneity is due to variable amounts of sialic acid that are terminally attached to a constant number of O-linked oligosaccharide chains per molecule. This carbohydrate, along with a small amount of N-linked carbohydrate, accounts for 50% of the apparent molecular size of murine MCP-1 and is not required for in vitro monocyte chemoattractant activity. Mutational analysis shows that most of the carbohydrate is added to a 49-amino acid C-terminal domain that is not present in human MCP-1 and is not required for in vitro biologic activity, suggesting that murine MCP-1 consists of an N-terminal domain containing monocyte chemoattractant activity and a heavily glycosylated C-terminal domain of as yet unknown function. MCP-1 produced in COS cells contains a small amount of sulfate, but Chinese hamster ovary-produced MCP-1 does not. The absence of sulfate does not alter MCP-1's in vitro chemoattractant properties. In vitro, highly purified murine MCP-1 attracts monocytes, but not neutrophils, with a specific activity similar to human MCP-1 (EC50 approximately 0.5 nM). Equilibrium binding experiments with human monocytes reveal the presence of approximately 3000 binding sites per cell with a Kd of 0.77 nM. In vivo, injection of up to 1 micrograms murine MCP-1 in a variety of murine strains induces the appearance of a sparse mixed inflammatory infiltrate. The disparity between MCP-1's in vitro and in vivo effects suggests that other factors may be required to elicit a full-blown monocyte chemotactic response to MCP-1 in vivo. FAU - Ernst, C A AU - Ernst CA AD - Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115. FAU - Zhang, Y J AU - Zhang YJ FAU - Hancock, P R AU - Hancock PR FAU - Rutledge, B J AU - Rutledge BJ FAU - Corless, C L AU - Corless CL FAU - Rollins, B J AU - Rollins BJ LA - eng GR - CA53091/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Chemokine CCL2) RN - 0 (Chemotactic Factors) RN - 0 (DNA Primers) RN - 0 (Glycoproteins) RN - 0 (Recombinant Proteins) RN - 0 (Sulfates) SB - IM MH - Animals MH - Base Sequence MH - Chemokine CCL2 MH - Chemotactic Factors/*chemistry MH - Chemotaxis, Leukocyte MH - DNA Primers/chemistry MH - Glycoproteins/chemistry MH - Glycosylation MH - Humans MH - Mice MH - Molecular Sequence Data MH - Monocytes/metabolism MH - Recombinant Proteins MH - Sulfates/chemistry EDAT- 1994/04/01 00:00 MHDA- 1994/04/01 00:01 CRDT- 1994/04/01 00:00 PHST- 1994/04/01 00:00 [pubmed] PHST- 1994/04/01 00:01 [medline] PHST- 1994/04/01 00:00 [entrez] PST - ppublish SO - J Immunol. 1994 Apr 1;152(7):3541-9.